Phase I study of CRISPR-engineered CAR-T cells with PD-1 inactivation in treating mesothelin-positive solid tumors
文献类型:期刊论文
作者 | Wang Zhenguang; Chen Meixia; Zhang Yan; Liu Yang; Yang Qingming; Nie Jing; Shen Lianjun; Jiang Pengfei; He Jiaping; Ye Xun |
刊名 | JOURNAL OF CLINICAL ONCOLOGY |
出版日期 | 2020 |
卷号 | 38期号:15 |
源URL | [http://ir.ioz.ac.cn/handle/000000/14558] |
专题 | 干细胞与生殖生物学国家重点实验室 |
推荐引用方式 GB/T 7714 | Wang Zhenguang,Chen Meixia,Zhang Yan,et al. Phase I study of CRISPR-engineered CAR-T cells with PD-1 inactivation in treating mesothelin-positive solid tumors[J]. JOURNAL OF CLINICAL ONCOLOGY,2020,38(15). |
APA | Wang Zhenguang.,Chen Meixia.,Zhang Yan.,Liu Yang.,Yang Qingming.,...&Han Weidong.(2020).Phase I study of CRISPR-engineered CAR-T cells with PD-1 inactivation in treating mesothelin-positive solid tumors.JOURNAL OF CLINICAL ONCOLOGY,38(15). |
MLA | Wang Zhenguang,et al."Phase I study of CRISPR-engineered CAR-T cells with PD-1 inactivation in treating mesothelin-positive solid tumors".JOURNAL OF CLINICAL ONCOLOGY 38.15(2020). |
入库方式: OAI收割
来源:动物研究所
浏览0
下载0
收藏0
其他版本
除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。